Aloe Therapeutics
Latest round
- Seed
Last raised
- Apr 2024
Total raised
- $0.1M
Investors
- 1
About Aloe Therapeutics
, operates as a healthcare technology company focused on developing cancer treatments. Their main area of interest is a local immunotherapy called allo-immunotherapy (AIM) designed to be implanted near tumors. The company offers cancer therapies, specifically focused on developing groundbreaking approaches in immunotherapy to transform the treatment landscape for solid tumors. The company’s therapy is designed to minimize systemic or overlapping toxicity with conventional cancer therapies.
Who invested in Aloe Therapeutics
1 investor across 1 round
See all investors in Aloe Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 8, 2024
Amount
$0.1M
Investors
Questions about Aloe Therapeutics
Who invested in Aloe Therapeutics?
Aloe Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aloe Therapeutics raised?
Aloe Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aloe Therapeutics last raise money?
Aloe Therapeutics's most recent round on record is a Seed, in Apr 2024.
What does Aloe Therapeutics do?
, operates as a healthcare technology company focused on developing cancer treatments.
Where is Aloe Therapeutics headquartered?
Aloe Therapeutics is headquartered in US.
Which VCs invest in companies like Aloe Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aloe Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Aloe Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.